| UniProt ID | MDHC_HUMAN | |
|---|---|---|
| UniProt AC | P40925 | |
| Protein Name | Malate dehydrogenase, cytoplasmic | |
| Gene Name | MDH1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 334 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | ||
| Protein Sequence | MSEPIRVLVTGAAGQIAYSLLYSIGNGSVFGKDQPIILVLLDITPMMGVLDGVLMELQDCALPLLKDVIATDKEDVAFKDLDVAILVGSMPRREGMERKDLLKANVKIFKSQGAALDKYAKKSVKVIVVGNPANTNCLTASKSAPSIPKENFSCLTRLDHNRAKAQIALKLGVTANDVKNVIIWGNHSSTQYPDVNHAKVKLQGKEVGVYEALKDDSWLKGEFVTTVQQRGAAVIKARKLSSAMSAAKAICDHVRDIWFGTPEGEFVSMGVISDGNSYGVPDDLLYSFPVVIKNKTWKFVEGLPINDFSREKMDLTAKELTEEKESAFEFLSSA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSEPIRVLV ------CCCCEEEEE | 52.67 | 25944712 | |
| 5 (in isoform 3) | Phosphorylation | - | 4.11 | 26437602 | |
| 14 | Acetylation | VLVTGAAGQIAYSLL EEEECCHHHHHHHHH | 20.92 | 19608861 | |
| 22 | Phosphorylation | QIAYSLLYSIGNGSV HHHHHHHHHCCCCCC | 11.97 | 22673903 | |
| 23 | Phosphorylation | IAYSLLYSIGNGSVF HHHHHHHHCCCCCCC | 24.80 | 22673903 | |
| 29 | Acetylation | YSIGNGSVFGKDQPI HHCCCCCCCCCCCCE | 8.54 | 19608861 | |
| 29 | Ubiquitination | YSIGNGSVFGKDQPI HHCCCCCCCCCCCCE | 8.54 | 19608861 | |
| 44 | Phosphorylation | ILVLLDITPMMGVLD EEEEEECHHHCCHHH | 12.56 | 24043423 | |
| 71 | Phosphorylation | LLKDVIATDKEDVAF HHHHHHCCCHHHCCC | 36.16 | 23911959 | |
| 73 | Acetylation | KDVIATDKEDVAFKD HHHHCCCHHHCCCCC | 52.00 | 23954790 | |
| 73 | Ubiquitination | KDVIATDKEDVAFKD HHHHCCCHHHCCCCC | 52.00 | 21906983 | |
| 89 | Phosphorylation | DVAILVGSMPRREGM CEEEEECCCCCCCCC | 20.38 | 22673903 | |
| 90 | Sulfoxidation | VAILVGSMPRREGME EEEEECCCCCCCCCC | 2.17 | 21406390 | |
| 103 | Acetylation | MERKDLLKANVKIFK CCHHHHHHHHHHHHH | 45.25 | 19608861 | |
| 103 | Succinylation | MERKDLLKANVKIFK CCHHHHHHHHHHHHH | 45.25 | 23954790 | |
| 103 | Ubiquitination | MERKDLLKANVKIFK CCHHHHHHHHHHHHH | 45.25 | 19608861 | |
| 107 | Acetylation | DLLKANVKIFKSQGA HHHHHHHHHHHHCCC | 42.08 | 23749302 | |
| 107 | Succinylation | DLLKANVKIFKSQGA HHHHHHHHHHHHCCC | 42.08 | 23954790 | |
| 107 | Ubiquitination | DLLKANVKIFKSQGA HHHHHHHHHHHHCCC | 42.08 | - | |
| 107 (in isoform 3) | Phosphorylation | - | 42.08 | 27251275 | |
| 110 | Acetylation | KANVKIFKSQGAALD HHHHHHHHHCCCHHH | 45.39 | 25953088 | |
| 110 | Malonylation | KANVKIFKSQGAALD HHHHHHHHHCCCHHH | 45.39 | 26320211 | |
| 110 | Methylation | KANVKIFKSQGAALD HHHHHHHHHCCCHHH | 45.39 | 38025153 | |
| 110 | Succinylation | KANVKIFKSQGAALD HHHHHHHHHCCCHHH | 45.39 | - | |
| 110 | Succinylation | KANVKIFKSQGAALD HHHHHHHHHCCCHHH | 45.39 | 27452117 | |
| 110 | Ubiquitination | KANVKIFKSQGAALD HHHHHHHHHCCCHHH | 45.39 | - | |
| 111 | Phosphorylation | ANVKIFKSQGAALDK HHHHHHHHCCCHHHH | 24.09 | 26657352 | |
| 118 | Acetylation | SQGAALDKYAKKSVK HCCCHHHHHCCCCCE | 48.21 | 22693256 | |
| 118 | Ubiquitination | SQGAALDKYAKKSVK HCCCHHHHHCCCCCE | 48.21 | 22693256 | |
| 119 | Phosphorylation | QGAALDKYAKKSVKV CCCHHHHHCCCCCEE | 24.26 | 28152594 | |
| 121 | Acetylation | AALDKYAKKSVKVIV CHHHHHCCCCCEEEE | 42.35 | 22693256 | |
| 121 | Ubiquitination | AALDKYAKKSVKVIV CHHHHHCCCCCEEEE | 42.35 | - | |
| 122 | Ubiquitination | ALDKYAKKSVKVIVV HHHHHCCCCCEEEEE | 52.92 | - | |
| 125 | Ubiquitination | KYAKKSVKVIVVGNP HHCCCCCEEEEECCC | 33.08 | 21890473 | |
| 129 (in isoform 3) | Phosphorylation | - | 4.16 | 24719451 | |
| 135 | Phosphorylation | VVGNPANTNCLTASK EECCCCCCCCCCCCC | 29.43 | 28348404 | |
| 136 | Ubiquitination | VGNPANTNCLTASKS ECCCCCCCCCCCCCC | 20.71 | 21890473 | |
| 136 | Ubiquitination | VGNPANTNCLTASKS ECCCCCCCCCCCCCC | 20.71 | 21890473 | |
| 136 | Acetylation | VGNPANTNCLTASKS ECCCCCCCCCCCCCC | 20.71 | 19608861 | |
| 136 | Ubiquitination | VGNPANTNCLTASKS ECCCCCCCCCCCCCC | 20.71 | 19608861 | |
| 137 | S-nitrosocysteine | GNPANTNCLTASKSA CCCCCCCCCCCCCCC | 3.17 | - | |
| 137 | S-nitrosylation | GNPANTNCLTASKSA CCCCCCCCCCCCCCC | 3.17 | 18335467 | |
| 137 | S-palmitoylation | GNPANTNCLTASKSA CCCCCCCCCCCCCCC | 3.17 | 26865113 | |
| 139 | Phosphorylation | PANTNCLTASKSAPS CCCCCCCCCCCCCCC | 30.96 | 28348404 | |
| 141 | Phosphorylation | NTNCLTASKSAPSIP CCCCCCCCCCCCCCC | 23.16 | 29507054 | |
| 142 | Acetylation | TNCLTASKSAPSIPK CCCCCCCCCCCCCCC | 48.44 | 26051181 | |
| 142 | Ubiquitination | TNCLTASKSAPSIPK CCCCCCCCCCCCCCC | 48.44 | - | |
| 143 | Ubiquitination | NCLTASKSAPSIPKE CCCCCCCCCCCCCCC | 42.80 | 21890473 | |
| 143 | Ubiquitination | NCLTASKSAPSIPKE CCCCCCCCCCCCCCC | 42.80 | 21890473 | |
| 143 | Phosphorylation | NCLTASKSAPSIPKE CCCCCCCCCCCCCCC | 42.80 | 26437602 | |
| 143 | Ubiquitination | NCLTASKSAPSIPKE CCCCCCCCCCCCCCC | 42.80 | 21890473 | |
| 146 | Phosphorylation | TASKSAPSIPKENFS CCCCCCCCCCCCCCC | 51.76 | 28188228 | |
| 149 | Acetylation | KSAPSIPKENFSCLT CCCCCCCCCCCCHHH | 64.72 | 26051181 | |
| 149 | Ubiquitination | KSAPSIPKENFSCLT CCCCCCCCCCCCHHH | 64.72 | - | |
| 153 | Phosphorylation | SIPKENFSCLTRLDH CCCCCCCCHHHHCCC | 21.57 | 26437602 | |
| 154 | S-nitrosylation | IPKENFSCLTRLDHN CCCCCCCHHHHCCCH | 3.83 | 24105792 | |
| 157 (in isoform 3) | Phosphorylation | - | 25.77 | 27251275 | |
| 164 | Ubiquitination | RLDHNRAKAQIALKL HCCCHHHHHHHHHHH | 37.27 | 21890473 | |
| 170 | Ubiquitination | AKAQIALKLGVTAND HHHHHHHHHCCCHHH | 33.89 | - | |
| 174 | Phosphorylation | IALKLGVTANDVKNV HHHHHCCCHHHCCEE | 20.25 | 22673903 | |
| 179 | Acetylation | GVTANDVKNVIIWGN CCCHHHCCEEEEECC | 48.65 | 25953088 | |
| 179 | Ubiquitination | GVTANDVKNVIIWGN CCCHHHCCEEEEECC | 48.65 | - | |
| 188 | Phosphorylation | VIIWGNHSSTQYPDV EEEECCCCCCCCCCC | 38.80 | 23401153 | |
| 189 | Phosphorylation | IIWGNHSSTQYPDVN EEECCCCCCCCCCCC | 16.39 | 28152594 | |
| 190 | Phosphorylation | IWGNHSSTQYPDVNH EECCCCCCCCCCCCC | 34.83 | 28152594 | |
| 192 | Phosphorylation | GNHSSTQYPDVNHAK CCCCCCCCCCCCCCE | 11.07 | 28152594 | |
| 199 | Acetylation | YPDVNHAKVKLQGKE CCCCCCCEEEECCEE | 32.14 | 25953088 | |
| 199 | Ubiquitination | YPDVNHAKVKLQGKE CCCCCCCEEEECCEE | 32.14 | - | |
| 201 | Ubiquitination | DVNHAKVKLQGKEVG CCCCCEEEECCEEEE | 34.09 | - | |
| 205 | Acetylation | AKVKLQGKEVGVYEA CEEEECCEEEEEEEE | 35.94 | 26051181 | |
| 205 | Ubiquitination | AKVKLQGKEVGVYEA CEEEECCEEEEEEEE | 35.94 | 21890473 | |
| 207 (in isoform 3) | Phosphorylation | - | 7.77 | 24719451 | |
| 208 (in isoform 3) | Phosphorylation | - | 19.85 | 27251275 | |
| 209 | Acetylation | LQGKEVGVYEALKDD ECCEEEEEEEECCCC | 4.76 | 19608861 | |
| 209 | Ubiquitination | LQGKEVGVYEALKDD ECCEEEEEEEECCCC | 4.76 | 19608861 | |
| 210 | Phosphorylation | QGKEVGVYEALKDDS CCEEEEEEEECCCCC | 6.91 | 25159151 | |
| 214 | Acetylation | VGVYEALKDDSWLKG EEEEEECCCCCCCCC | 67.54 | 26822725 | |
| 214 | Succinylation | VGVYEALKDDSWLKG EEEEEECCCCCCCCC | 67.54 | - | |
| 214 | Succinylation | VGVYEALKDDSWLKG EEEEEECCCCCCCCC | 67.54 | 23954790 | |
| 214 | Ubiquitination | VGVYEALKDDSWLKG EEEEEECCCCCCCCC | 67.54 | 21890473 | |
| 217 | Phosphorylation | YEALKDDSWLKGEFV EEECCCCCCCCCCEE | 44.43 | 28857561 | |
| 220 | Ubiquitination | LKDDSWLKGEFVTTV CCCCCCCCCCEEEEH | 50.57 | 21890473 | |
| 223 | Ubiquitination | DSWLKGEFVTTVQQR CCCCCCCEEEEHHHH | 8.90 | 21890473 | |
| 223 | Ubiquitination | DSWLKGEFVTTVQQR CCCCCCCEEEEHHHH | 8.90 | 21890473 | |
| 223 | Ubiquitination | DSWLKGEFVTTVQQR CCCCCCCEEEEHHHH | 8.90 | 21890473 | |
| 228 (in isoform 3) | Phosphorylation | - | 25.76 | 27642862 | |
| 230 | Methylation | FVTTVQQRGAAVIKA EEEEHHHHCHHHHHH | 21.45 | 58858501 | |
| 232 | Ubiquitination | TTVQQRGAAVIKARK EEHHHHCHHHHHHHH | 10.76 | 21890473 | |
| 232 | Ubiquitination | TTVQQRGAAVIKARK EEHHHHCHHHHHHHH | 10.76 | 21890473 | |
| 232 | Ubiquitination | TTVQQRGAAVIKARK EEHHHHCHHHHHHHH | 10.76 | 21890473 | |
| 235 (in isoform 3) | Phosphorylation | - | 2.18 | 27251275 | |
| 236 | Acetylation | QRGAAVIKARKLSSA HHCHHHHHHHHHHHH | 35.22 | 25953088 | |
| 236 | Ubiquitination | QRGAAVIKARKLSSA HHCHHHHHHHHHHHH | 35.22 | - | |
| 239 | Acetylation | AAVIKARKLSSAMSA HHHHHHHHHHHHHHH | 58.54 | 25953088 | |
| 239 | Ubiquitination | AAVIKARKLSSAMSA HHHHHHHHHHHHHHH | 58.54 | - | |
| 241 | Phosphorylation | VIKARKLSSAMSAAK HHHHHHHHHHHHHHH | 21.06 | 29255136 | |
| 242 | Phosphorylation | IKARKLSSAMSAAKA HHHHHHHHHHHHHHH | 38.13 | 30266825 | |
| 244 | Sulfoxidation | ARKLSSAMSAAKAIC HHHHHHHHHHHHHHH | 2.79 | 30846556 | |
| 245 | Phosphorylation | RKLSSAMSAAKAICD HHHHHHHHHHHHHHH | 25.45 | 30266825 | |
| 248 | Acetylation | SSAMSAAKAICDHVR HHHHHHHHHHHHHHH | 37.69 | 25953088 | |
| 259 (in isoform 3) | Phosphorylation | - | 8.79 | 24719451 | |
| 277 | Phosphorylation | GVISDGNSYGVPDDL EEECCCCCCCCCCCC | 28.88 | 30576142 | |
| 278 | Phosphorylation | VISDGNSYGVPDDLL EECCCCCCCCCCCCE | 26.58 | 30576142 | |
| 296 | Phosphorylation | PVVIKNKTWKFVEGL CEEEECCCEEEECCC | 43.19 | 22673903 | |
| 298 | Acetylation | VIKNKTWKFVEGLPI EEECCCEEEECCCCC | 44.77 | 22693256 | |
| 298 | Succinylation | VIKNKTWKFVEGLPI EEECCCEEEECCCCC | 44.77 | - | |
| 298 | Succinylation | VIKNKTWKFVEGLPI EEECCCEEEECCCCC | 44.77 | 19608861 | |
| 298 | Ubiquitination | VIKNKTWKFVEGLPI EEECCCEEEECCCCC | 44.77 | 22693256 | |
| 309 | Phosphorylation | GLPINDFSREKMDLT CCCCCCCCHHHCCCC | 42.25 | 21712546 | |
| 312 | Acetylation | INDFSREKMDLTAKE CCCCCHHHCCCCHHH | 36.28 | 25953088 | |
| 312 | Ubiquitination | INDFSREKMDLTAKE CCCCCHHHCCCCHHH | 36.28 | - | |
| 316 | Ubiquitination | SREKMDLTAKELTEE CHHHCCCCHHHHHHH | 31.27 | 21890473 | |
| 316 | Ubiquitination | SREKMDLTAKELTEE CHHHCCCCHHHHHHH | 31.27 | 21890473 | |
| 316 | Acetylation | SREKMDLTAKELTEE CHHHCCCCHHHHHHH | 31.27 | 19608861 | |
| 316 | Phosphorylation | SREKMDLTAKELTEE CHHHCCCCHHHHHHH | 31.27 | 28634298 | |
| 316 | Ubiquitination | SREKMDLTAKELTEE CHHHCCCCHHHHHHH | 31.27 | 19608861 | |
| 318 | Succinylation | EKMDLTAKELTEEKE HHCCCCHHHHHHHHH | 48.28 | - | |
| 318 | Succinylation | EKMDLTAKELTEEKE HHCCCCHHHHHHHHH | 48.28 | 23954790 | |
| 318 | Ubiquitination | EKMDLTAKELTEEKE HHCCCCHHHHHHHHH | 48.28 | 21890473 | |
| 321 | Phosphorylation | DLTAKELTEEKESAF CCCHHHHHHHHHHHH | 43.09 | 21712546 | |
| 324 | Ubiquitination | AKELTEEKESAFEFL HHHHHHHHHHHHHHH | 51.22 | 21890473 | |
| 326 | Phosphorylation | ELTEEKESAFEFLSS HHHHHHHHHHHHHHC | 49.69 | 28176443 | |
| 332 | Phosphorylation | ESAFEFLSSA----- HHHHHHHHCC----- | 29.55 | 30108239 | |
| 333 | Phosphorylation | SAFEFLSSA------ HHHHHHHCC------ | 39.90 | 28176443 | |
| 336 | Ubiquitination | EFLSSA--------- HHHHCC--------- | 21890473 | ||
| 336 | Ubiquitination | EFLSSA--------- HHHHCC--------- | 21890473 | ||
| 350 (in isoform 3) | Phosphorylation | - | 27251275 | ||
| 351 (in isoform 3) | Phosphorylation | - | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MDHC_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 118 | K | Acetylation |
| 19608861 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MDHC_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| P53_HUMAN | TP53 | physical | 19229245 | |
| PRDX6_HUMAN | PRDX6 | physical | 22939629 | |
| NHRF1_HUMAN | SLC9A3R1 | physical | 22939629 | |
| PRDX5_HUMAN | PRDX5 | physical | 22939629 | |
| PGM1_HUMAN | PGM1 | physical | 22939629 | |
| ESTD_HUMAN | ESD | physical | 26344197 | |
| GLRX1_HUMAN | GLRX | physical | 26344197 | |
| AATC_HUMAN | GOT1 | physical | 26344197 | |
| PDXK_HUMAN | PDXK | physical | 26344197 | |
| PGM1_HUMAN | PGM1 | physical | 26344197 | |
| PGM2_HUMAN | PGM2 | physical | 26344197 | |
| SCPDL_HUMAN | SCCPDH | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-103; LYS-118 AND LYS-298,AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |